OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 1 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81 | -25.7% | 25,963 | +22.9% | 0.00% | – |
| Q2 2023 | $109 | -92.6% | 21,123 | -92.4% | 0.00% | -100.0% |
| Q1 2023 | $1,473 | +64.4% | 279,687 | -12.3% | 0.00% | – |
| Q4 2022 | $896 | -93.6% | 318,834 | +9659.2% | 0.00% | – |
| Q3 2022 | $14,000 | -78.8% | 3,267 | -80.0% | 0.00% | – |
| Q2 2022 | $66,000 | -59.0% | 16,369 | -49.6% | 0.00% | – |
| Q1 2022 | $161,000 | -90.8% | 32,481 | -87.0% | 0.00% | – |
| Q4 2021 | $1,746,000 | +130.6% | 250,624 | +230.9% | 0.00% | – |
| Q3 2021 | $757,000 | +227.7% | 75,737 | +362.7% | 0.00% | – |
| Q2 2021 | $231,000 | -78.6% | 16,368 | -75.1% | 0.00% | -100.0% |
| Q1 2021 | $1,077,000 | +132.1% | 65,631 | +192.6% | 0.00% | – |
| Q4 2020 | $464,000 | +100.9% | 22,428 | -26.3% | 0.00% | – |
| Q3 2020 | $231,000 | -6.1% | 30,447 | +3.0% | 0.00% | – |
| Q2 2020 | $246,000 | +251.4% | 29,571 | +110.8% | 0.00% | – |
| Q1 2020 | $70,000 | -58.3% | 14,029 | -67.0% | 0.00% | – |
| Q4 2019 | $168,000 | -1.8% | 42,465 | -24.4% | 0.00% | – |
| Q3 2019 | $171,000 | -41.0% | 56,197 | -14.5% | 0.00% | – |
| Q2 2019 | $290,000 | +218.7% | 65,763 | +187.5% | 0.00% | – |
| Q1 2019 | $91,000 | +3.4% | 22,878 | +2.9% | 0.00% | – |
| Q4 2018 | $88,000 | -72.9% | 22,229 | -53.0% | 0.00% | – |
| Q3 2018 | $325,000 | +100.6% | 47,346 | +96.5% | 0.00% | – |
| Q2 2018 | $162,000 | -12.0% | 24,092 | -14.8% | 0.00% | – |
| Q1 2018 | $184,000 | +922.2% | 28,262 | +587.0% | 0.00% | – |
| Q4 2017 | $18,000 | -65.4% | 4,114 | -51.7% | 0.00% | – |
| Q3 2017 | $52,000 | +642.9% | 8,520 | +955.8% | 0.00% | – |
| Q2 2017 | $7,000 | -97.7% | 807 | -97.6% | 0.00% | – |
| Q1 2017 | $308,000 | +1040.7% | 33,256 | +916.1% | 0.00% | – |
| Q4 2016 | $27,000 | +1250.0% | 3,273 | +998.3% | 0.00% | – |
| Q3 2016 | $2,000 | -90.0% | 298 | -92.4% | 0.00% | – |
| Q2 2016 | $20,000 | +11.1% | 3,905 | +92.6% | 0.00% | – |
| Q1 2016 | $18,000 | -61.7% | 2,028 | -61.3% | 0.00% | – |
| Q4 2015 | $47,000 | -44.7% | 5,237 | -13.6% | 0.00% | – |
| Q3 2015 | $85,000 | -14.1% | 6,059 | +28.1% | 0.00% | – |
| Q2 2015 | $99,000 | +1314.3% | 4,729 | +2633.5% | 0.00% | – |
| Q1 2015 | $7,000 | -88.5% | 173 | -93.4% | 0.00% | – |
| Q4 2014 | $61,000 | – | 2,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $19,223 | 100.00% |
| Opaleye Management Inc. | 6,468,000 | $20,309,520 | 6.61% |
| DELTEC ASSET MANAGEMENT LLC | 2,061,797 | $6,474,043 | 1.48% |
| Endurant Capital Management LP | 353,707 | $1,110,640 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 969,350 | $3,043,759 | 0.59% |
| NOTTINGHAM ADVISORS, INC. | 194,266 | $609,995 | 0.09% |
| Covestor Ltd | 37,404 | $117 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 233,582 | $733 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 342,111 | $1,074,229 | 0.03% |
| Polar Asset Management Partners Inc. | 263,763 | $828,216 | 0.02% |